Skip to main content
. 2023 Nov 16;13:1239118. doi: 10.3389/fonc.2023.1239118

Table 5.

225Ac-J591.

225Ac-J591 Information
PSA Response
41% of 22 patients experienced >50% PSA decrease.
Unwanted Side Effects
One patient had anemia and level 4 thrombocytopenia after dose.
Ongoing Studies
Further studies on 225Ac-J591 are in progres.